Clinical Trial Update: Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

This document reports a completed Phase 1/2 clinical trial of rapamycin therapy for head and neck squamous cell carcinoma, with results posted in 2017. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Oral Cavity Cancer
• Squamous Cell Carcinoma
• Tongue Cancer

Drugs mentioned

• Rapamycin (sirolimus)

Snippet

Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) | Conditions: Mouth Neoplasms, Head and Neck Neoplasms | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-01-19